ENZYME CATALYSIS AND REGULATION
Functional Characterization of Δ32-Enoyl-CoA Isomerases from Rat Liver*

https://doi.org/10.1074/jbc.M112228200Get rights and content
Under a Creative Commons license
open access

The degradation of unsaturated fatty acids by β-oxidation involves Δ32-enoyl-CoA isomerases (enoyl-CoA isomerases) that catalyze 3-cis → 2-trans and 3-trans → 2-trans isomerizations of enoyl-CoAs and the 2,5 → 3,5 isomerization of dienoyl-CoAs. An analysis of rat liver enoyl-CoA isomerases revealed the presence of a monofunctional enoyl-CoA isomerase (ECI) in addition to mitochondrial enoyl-CoA isomerase (MECI) in mitochondria, whereas peroxisomes contain ECI and multifunctional enzyme 1 (MFE1). Thus ECI, which previously had been described as peroxisomal enoyl-CoA isomerase, was found to be present in both peroxisomes and mitochondria. This enzyme seems to be identical with mitochondrial long-chain enoyl-CoA isomerase (Kilponen, J.M., Palosaari, P.M., and Hiltunen, J.K. 1990. Biochem. J. 269, 223–226). All three hepatic enoyl-CoA isomerases have broad chain length specificities but are distinguishable by their preferences for one of the three isomerization reactions. MECI is most active in catalyzing the 3-cis → 2-trans isomerization; ECI has a preference for the 3-trans → 2-trans isomerization, and MFE1 is the optimal isomerase for the 2,5 → 3,5 isomerization. A functional characterization based on substrate specificities and total enoyl-CoA isomerase activities in rat liver leads to the conclusion that the 3-cis → 2-trans and 2,5 → 3,5 isomerizations in mitochondria are catalyzed overwhelmingly by MECI, whereas ECI contributes significantly to the 3-trans → 2-trans isomerization. In peroxisomes, ECI is predicted to be the dominant enzyme for the 3-cis → 2-trans and 3-trans → 2-transisomerizations of long-chain intermediates, whereas MFE1 is the key enzyme in the 2,5 → 3,5 isomerization.

Cited by (0)

Published, JBC Papers in Press, January 7, 2002, DOI 10.1074/jbc.M112228200

*

This work was supported by United States Public Health Service Grant HL30847 from the NHLBI, National Institutes of Health, and by Grant RR03060 to Research Centers of Minority Institutions.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.